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Abstract
Pneumolysin (PLY) is a key Streptococcus pneumoniae virulence factor and potential candidate for inclusion in
pneumococcal subunit vaccines. Dendritic cells (DC) play a key role in the initiation and instruction of adaptive immunity,
but the effects of PLY on DC have not been widely investigated. Endotoxin-free PLY enhanced costimulatory molecule
expression on DC but did not induce cytokine secretion. These effects have functional significance as adoptive transfer of
DC exposed to PLY and antigen resulted in stronger antigen-specific T cell proliferation than transfer of DC exposed to
antigen alone. PLY synergized with TLR agonists to enhance secretion of the proinflammatory cytokines IL-12, IL-23, IL-6, IL-
1b, IL-1a and TNF-a by DC and enhanced cytokines including IL-17A and IFN-c by splenocytes. PLY-induced DC maturation
and cytokine secretion by DC and splenocytes was TLR4-independent. Both IL-17A and IFN-c are required for protective
immunity to pneumococcal infection and intranasal infection of mice with PLY-deficient pneumococci induced significantly
less IFN-c and IL-17A in the lungs compared to infection with wild-type bacteria. IL-1b plays a key role in promoting IL-17A
and was previously shown to mediate protection against pneumococcal infection. The enhancement of IL-1b secretion by
whole live S. pneumoniae and by PLY in DC required NLRP3, identifying PLY as a novel NLRP3 inflammasome activator.
Furthermore, NLRP3 was required for protective immunity against respiratory infection with S. pneumoniae. These results
add significantly to our understanding of the interactions between PLY and the immune system.
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Introduction
Streptococcus pneumoniae is responsible for millions of deaths
annually from pneumonia, meningitis and septicaemia while also
causing other less serious infections, such as otitis media and
sinusitis. Pneumolysin (PLY) is a major virulence factor that is
expressed by virtually all clinical isolates of the bacterium. The
toxin is a member of the cholesterol-dependent cytolysins, a family
that includes perfringolysin O and streptolysin O, expressed by
Clostridium perfringens and Streptococcus pyogenes, respectively. A
classical feature of these toxins is their ability to create
transmembrane pores in cholesterol-containing membranes and
thereby cause cell lysis (reviewed in [1]).
The importance of PLY as a pneumococcal virulence factor is
well established, with several studies showing reduced pathogenesis
in mice infected with PLY-deficient strains of S. pneumoniae,
compared to isogenic toxin-producing strains [2,3,4,5]. Further-
more, application of PLY directly into the lungs of rats induced an
acute inflammatory response similar to that observed during
pneumococcal pneumonia [6]. At sublytic concentrations, the
toxin has been reported to promote activation of host complement
[7], potentiation of neutrophil activity [8,9], activation and
chemotaxis of CD4+ T cells [10] and enhanced production of
proinflammatory cytokines in macrophages and monocytes
[11,12]. Studies have been carried out to address the mechanisms
underlying the immunomodulatory effects of PLY and particularly
the role of TLRs. It has been proposed that the ability of PLY to
induce cytokine production [13] and apoptosis [14] in peritoneal
macrophages was TLR4-dependent. In contrast, the activation of
p38 mitogen-activated protein kinase in epithelial cells [15] and
the activation of nuclear factor of activated T cells (NFAT) [16] by
PLY were reported to be TLR4-independent. Furthermore, there
are conflicting reports on the role of TLR4 in defence against
pneumococcal infection. TLR4 was reported to be required for
host defence against PLY-producing pneumococci, as mice lacking
functional TLR4 were more susceptible to disease after nasopha-
ryngeal challenge [13]. However, other studies have shown a more
limited or indeed a redundant role for TLR4 in host resistance to
pneumococcal disease, depending on the bacterial dose and the
model of infection [17,18]. Thus, the role of TLR4 in immune
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responses to the pneumococcus, and particularly to PLY, is
unclear and must be resolved.
T cells play a key role in protection against pneumococcal
infection [4,10] so it is important to determine the factors
underlying pneumococcus-induced T cell responses. In this regard
it is noteworthy that studies in IFN-c2/2 mice indicate a
protective role for IFN-c during bacteremic pneumococcal
pneumonia [19] and administration of recombinant IFN-c to
mice promoted protection from disease following intratracheal
infection with S. pneumoniae [20]. Furthermore, an essential role
was proposed for IL-17A in protection against pneumococcal
nasopharyngeal colonization following intranasal immunization of
mice with killed pneumococci and cholera toxin adjuvant, as
protection was abrogated in mice deficient in the IL-17A receptor
[21]. Thus, there is a strong rationale for the development of
vaccination approaches that induce IFN-c- and IL-17A-producing
cells and for understanding the mechanisms by which pneumo-
cocci may either promote or evade such responses.
The activation and differentiation of naı¨ve CD4+T cells following
immunization or infection depends on interactions with DC [22]. T
cell activation requires antigen presentation on MHC class II
molecules, as well as costimulatory signals provided by molecules
including CD80 and CD86 on the DC surface. The differentiation
of Th1 and Th17 cells requires polarizing cytokines which can be
produced by DC. IL-12 and IL-18 are two of the key cytokines
involved in Th1 cell differentiation, while IL-23, IL-1 and IL-6
promote Th17 cell development. To date, little is known about the
interaction of PLY with DC. Therefore, in this study the effects of
PLY on DC maturation and cytokine production and the role of
TLR4 in these processes were determined. In addition to the key
role of DC in dictating T cell differentiation and polarization,
important roles for natural killer (NK) cells and cd T cells have also
been described. In particular, IFN-c produced by NK cells plays a
key role in the instruction of Th1 responses [23], while IL-17A
derived from cd T cells promotes Th17 responses [24].
We demonstrate that endotoxin-free PLY alone does not
induce cytokine production by DC or macrophages but it can
synergize with TLR agonists to enhance cytokine secretion.
Furthermore, PLY promotes the secretion of cytokines including
IFN-c and IL-17A by splenocytes and is essential for S. pneumoniae
to promote the production of IFN-c by NK cells and IL-17A by
cd T cells in the lung following respiratory infection. In contrast
to previous publications showing a role for TLR4 in PLY-induced
immune responses, we show that the ability of the toxin to
enhance cytokine secretion does not require TLR4. However,
NLRP3 activation was required for PLY- and live S. pneumoniae-
mediated enhancement of IL-1b secretion and NLRP3 was
required for protection against respiratory infection with
S. pneumoniae.
Results
PLY induces TLR4-independent secretion of
proinflammatory cytokines by splenocytes
IFN-c and IL-17 responses play an essential role in protective
immunity against pneumococcal disease [19,20,21]. We therefore
investigated the ability of PLY to promote these cytokines in vitro
and the requirement for TLR4. In the absence of any stimulation
with PMA or anti-CD3, PLY alone was unable to promote
cytokine secretion by splenocytes (data not shown). However, we
did find significant enhancing effects of PLY on IFN-c secretion by
splenocytes stimulated with heat-killed S. pneumoniae (HkSp) and
PMA/ionomycin (Fig. 1A). This was true for spleen cells from
both C3H/HeN and C3H/HeJ mice, indicating that the
combination of PLY and HkSp is a potent stimulus for TLR4-
independent IFN-c secretion in spleen cells (Fig. 1A). The IFN-c
inducing ability of the toxin was not dependent on its cytolytic
activity as a mutant of PLY (W433F) with greatly reduced
cytotoxic activity was also capable of stimulating IFN-c production
by splenocytes (Fig. 1A). Indeed, concentrations of W433F from
0.32–200 ng/ml enhanced pneumococci-induced IFN-c produc-
tion, whereas the wild-type toxin only significantly augmented
IFN-c secretion at a concentration of 0.32 ng/ml (Fig. 1A). The
pore-forming activity of the toxin may, therefore, interfere with its
ability to stimulate IFN-c production in splenocytes.
Furthermore, in the presence of anti-CD3, PLY significantly
augmented IFN-c secretion by splenocytes (Fig. 1B). We also
examined the ability of PLY to induce the secretion of other
cytokines by anti-CD3-stimulated splenocytes. At a concentration
of 1.6 ng/ml, PLY significantly enhanced IL-5 (3-fold; P,0.05),
IL-10 (3-fold; P,0.05) and IL-17A (2-fold; P,0.05), in addition to
IFN-c (14-fold; P,0.001), secretion by splenocytes from TLR4
hyporesponsive C3H/HeJ mice (Fig. 1B). These data demonstrate
that PLY induces cytokine secretion by spleen cells in a TLR4-
independent manner. PLY at 1.6 ng/ml was more effective at
promoting cytokine secretion than at 40 ng/ml (Fig. 1B). How-
ever, a concentration of 40 ng/ml PLY may induce early
apoptosis in splenocytes, as dual staining of these cells with
AnnexinV and propidium iodide (PI) revealed slight increases in
AnnexinV+/PI- cells following incubation with the toxin for
6 hours (Fig. S1A). These increases were more apparent following
stimulation with 200 ng/ml PLY (Fig. S1A). In contrast, when
splenocytes were incubated with 200 ng/ml PLY for 24 hours or
96 hours there was no increase in AnnexinV+/PI- cells (data not
shown), although an increase in the percentage of PI+ cells was
evident (Fig. S1B and S1C). Higher concentrations of PLY (1–
5 mg/ml) induced the death of .25% of splenocytes from either
C3H/HeN or C3H/HeJ mice after 24 hours (Fig. S1B) and this
increased to .50% by 96 hours (Fig. S1C).
Author Summary
Streptococcus pneumoniae (pneumococcus) is a pathogen
of global significance, causing diseases including pneu-
monia, meningitis and septicaemia. In order to develop
improved pneumococcal vaccines it is essential to
understand how the bacterium interacts with the host
immune system. Pneumococci produce a range of
pathogenicity factors, among which the toxin pneumoly-
sin plays a central role and has potential as a vaccine
candidate. Here, we demonstrate that pneumolysin can
directly activate innate immune cells and dramatically
amplify the production of pro-inflammatory cytokines.
These enhancing effects of the toxin do not require Toll-
like receptor (TLR)4. In particular, the toxin exerts a potent
effect on interleukin (IL)-1, which is an endogenous
pyrogen and powerful activator of IL-17A production. This
effect results from activation of the NLRP3 inflammasome
complex and NLRP3 is required for protection against the
pathogen in vivo. To induce protective immunity against
pneumococci, IFN-c and IL-17A are thought to be
essential. We show that pneumolysin plays a key role in
promoting these cytokines both in vitro and in vivo during
respiratory infection. The results add significantly to our
understanding of the interactions between pneumococci
and the immune system and support investigations into
the inclusion of pneumolysin or its derivatives in novel
pneumococcal vaccines.
Pneumolysin Promotes NLRP3 Inflammasome Activation
PLoS Pathogens | www.plospathogens.org 2 November 2010 | Volume 6 | Issue 11 | e1001191
Figure 1. PLY enhances cytokine production by splenocytes independently of TLR4. (A) Spleen cells from C3H/HeN and C3H/HeJ mice
were incubated for 72 hours with PLY (0.32–200 ng/ml) (58,500 HU/mg) or W433F in the presence or absence of HkSp (1 bacterium:1 spleen cell).
Splenocytes were then stimulated with PMA (5 mg/ml) and ionomycin (300 ng/ml) for a further 24 hours to activate the cells. IFN-c concentrations
were determined in supernatants. ** P,0.01 and *** P,0.001 vs. bacteria + PMA/ionomycin alone. (B) Spleen cells (16106/ml) from C3H/HeJ mice
were incubated with plate-bound anti-CD3 (10 mg/ml) alone or with PLY (0.064–40 ng/ml) (58,500 HU/mg). IFN-c, IL-5, IL-10 and IL-17A were
measured in supernatants after 72 hours. * P,0.05 and *** P,0.001 vs. anti-CD3 alone. +P,0.05 vs. 1.6 ng/ml. All cytokine concentrations are
presented as the mean (+ SEM) for triplicate samples.
doi:10.1371/journal.ppat.1001191.g001
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PLY is required for the induction of IFN-c and IL-17A
responses following pneumococcal infection
Having shown that PLY enhanced the secretion of cytokines,
including IFN-c and IL-17A by splenocytes stimulated in vitro
(Fig. 1), we next determined the contribution of PLY to
pneumococcus-induced cytokine production using two different
murine models of pneumococcal infection in vivo. Using a model of
acute pneumonia [4], we found that infection with a PLY-deficient
strain of pneumococcus (PLN-A) induced significantly less IFN-c in
the lungs of mice compared to infection with its PLY-positive
parental strain (Fig. 2A). As has been demonstrated previously in
this pneumonia model [3,4,5], the PLY-deficient strain exhibited
reduced virulence in the lungs compared to the wild-type strain (Fig.
S2A). Furthermore, using a model of resolving pneumonia [25,26],
we found significantly lower concentrations of IL-17A in the lungs of
mice infected with PLN-A compared to those infected with wild-
type pneumococci, at both 24 and 48 hours post-infection (Fig. 2B).
There were no significant differences in bacterial CFU at time 0 in
the lungs of mice infected with wild-type bacteria compared to PLY-
deficient bacteria and lung CFU of both pneumococcal strains were
reduced at 24 and 48 hours post-infection (Fig. S2B).
We then investigated the cellular source of these cytokines by
intracellular cytokine staining. NK cells were the principal source
of IFN-c in the lungs 48 hours following infection, although IFN-c
was also produced by cd T cells and other T cells (Fig. 2C and 2E).
In the case of IL-17A, the enhanced cytokine production was
predominately by cd T cells with limited IL-17A production in
other T cells and NK cells (Fig. 2D and 2E).
PLY promotes dendritic cell maturation but not cytokine
production
Having shown that PLY promotes IFN-c and IL-17A
production in vitro and in vivo, we next established the effects of
the toxin on DC. DC play an important role in the activation and
polarization of naı¨ve T cells but to date the effects of PLY on DC
have not been widely investigated. We therefore examined the
effects of PLY on DC cytokine production and costimulatory
molecule expression.
While the TLR2 agonist PAM3Csk4 promoted the secretion of
proinflammatory cytokines from DC, endotoxin-free PLY, at
concentrations of up to 1 mg/ml, did not induce the secretion of
IL-6, IL-12p40 or TNF-a (Fig. 3A). Higher concentrations were
not tested because PLY at 2 mg/ml caused some cell death in DC,
as determined by PI staining (Fig. S3A). Indeed, concentrations of
PLY ranging from 3 mg/ml to 6 mg/ml were highly toxic to DC,
with PLY at 6 mg/ml inducing death in approximately 90% of DC
from either C3H/HeN or C3H/HeJ mice after 24 hours (Fig.
S3A and S3B). AnnexinV/PI staining of DC incubated with this
higher concentration of the toxin for 6 hours indicated that PLY
induced limited apoptosis (AnnexinV+/PI2), but greatly increased
the percentage of dead AnnexinV+/PI+ cells (Fig. S3C).
Since previous studies demonstrated that PLY could directly
induce cytokine production in monocytes and macrophages [12,13],
it was important to establish if the finding that endotoxin-free PLY
does not promote cytokine secretion was specific to DC. Endotoxin-
free PLY was also unable to induce secretion of significant
concentrations of IL-6, TNF-a, IL-12p40 (Fig. 3B), IL-1b or IL-23
(data not shown) from murine bone-marrow derived macrophages
(BMDM). These data indicate that PLY alone does not stimulate
inflammatory cytokine production by DC or macrophages.
Since co-stimulation is required for DC to promote T cell
activation, we assessed the effects of PLY on the expression of co-
stimulatory molecules and MHC class II on DC and compared
these effects to those induced by the TLR4 agonist LPS.
Stimulation of DC with endotoxin-free PLY enhanced the
expression of MHC class II and co-stimulatory molecules,
particularly CD86. Interestingly, similar findings were observed
with PLY-stimulated DC from both C3H/HeN and LPS-
hyporesponsive C3H/HeJ mice, indicating that the enhancement
of DC maturation by the toxin was TLR4-independent. In
contrast, LPS strongly enhanced the expression of co-stimulatory
molecules on DC from C3H/HeN mice only (Fig. 3C). Therefore,
although endotoxin-free PLY does not induce cytokine secretion
by DC, it can promote their maturation independently of TLR4.
To determine the functional significance of the direct effects of
PLY on DC, cells were incubated with antigen (KLH) alone or
KLH and PLY overnight and injected into mice. The exposure of
DC to PLY increased their ability to promote antigen-specific T
cell proliferation in splenocytes 7 days following DC transfer
(Fig. 3D). We did not detect enhanced antigen-specific cytokine
production by these cells (data not presented). However, the T cell
proliferation data indicate that PLY can act directly on DC to
enhance their T cell stimulatory activity.
Since exposure of DC to PLY enhanced their ability to promote
adaptive immune responses, we determined the adjuvant proper-
ties of endotoxin-free PLY when co-injected with KLH. Injection
of PLY with KLH did not enhance antigen-specific cellular
immune responses (Fig. S4A). In contrast, antigen-specific
antibody responses were significantly enhanced by co-immuniza-
tion with antigen and PLY (Fig. S4B and S4C). The ability of PLY
to promote antigen-specific antibody responses applied to both
IgG1 and IgG2a subclasses and the toxin was equally effective in
C3H/HeN and C3H/HeJ mice. Thus, the toxin has the ability to
enhance antigen-specific immune responses independently of
TLR4 signalling.
PLY synergizes with TLR agonists to enhance secretion of
pro-inflammatory cytokines
Although PLY alone did not induce cytokine production by DC
or macrophages, we investigated if the toxin could synergize with
other stimuli to enhance cytokine secretion. We found that PLY
(1 mg/ml) synergized with HkSp to significantly enhance the
secretion of IL-6, IL-12p40, IL-23 and TNF-a by DC (Fig. 4A).
Notably, this synergistic effect was observed in DC from both
C3H/HeN and C3H/HeJ mice, indicating that the enhancement
of cytokine secretion by PLY did not require the presence of
functional TLR4. Furthermore, PLY was also able to synergize
with HkSp to significantly enhance IL-6 and TNF-a production in
BMDM (Fig. S5). PLY alone did not induce significant secretion of
IL-1a or IL-1b by DC (Fig. 4B) or BMDM (data not shown).
However, PLY synergized with HkSp to significantly enhance IL-
1b secretion by DC (Fig. 4B). Importantly, the ability of PLY to
promote IL-1b secretion was not limited to pneumococci as the
toxin also significantly enhanced IL-1b secretion in response to a
range of TLR and NLR agonists; PAM3Csk (TLR1/2 ligand),
zymosan (TLR2/6 ligand), CpG (TLR9 ligand) and MDP (Nod2
ligand). Similarly, IL-1a secretion was significantly enhanced in
DC stimulated with these TLR/NLR agonists and PLY compared
to the agonists alone. Furthermore, by using DC from C3H/HeJ
mice, we showed that PLY-induced enhancement of IL-1a and IL-
1b secretion by TLR agonists was independent of TLR4 (Fig. 4B).
PLY activates the NLRP3 inflammasome
Since it has been shown that IL-1b is required for resistance to
pneumococcal infection [27], we investigated the mechanism
underlying PLY-induced IL-1b further. Firstly, to determine the
importance of haemolytic activity in the promotion of IL-1b by
Pneumolysin Promotes NLRP3 Inflammasome Activation
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Figure 2. PLY is required for IFN-c and IL-17A induction following infection with S. pneumoniae. (A) IFN-c concentrations in lungs of
infected mice in a model of acute pneumonia. MF1 mice were infected intranasally with wild-type (WT) or PLY-deficient (PLN-A) pneumococci. IFN-c
concentrations were determined in lung homogenates at 0 hours, 24 hours or 48 hours after infection. Results are mean cytokine concentration (+
SEM) for 5 mice per group. *** P,0.001 vs. WT. (B) IL-17A concentrations in lungs of infected mice in a model of resolving pneumonia. BALB/c mice
were infected intranasally with WT or PLN-A pneumococci. IL-17A concentrations were determined in lungs at 0 hours, 24 hours or 48 hours after
infection. Results are mean cytokine concentration (+ SEM) for 5 mice per group. ** P,0.01 and *** P,0.001 vs. WT. (C–E) Intracellular cytokine
staining for IFN-c and IL-17A in the lungs of S. pneumoniae infected mice. Lung cells were isolated from BALB/c mice 48 hours after intranasal
infection with wild-type S. pneumoniae (D39). Cells were cultured for 5 hours with brefeldin A (GolgiPlug) in the presence of PMA and ionomycin
followed by incubation with fluorescently-labelled antibodies against CD3e, CD4, CD8, NKp46, NK1.1, CD45, cdTCR, IFN-c and IL-17A. Representative
dot plots for IFN-c production by NK cells (panel C; gated on CD4 and NKp46) and IL-17A production by cd T cells (panel D; gated on side scatter and
cdTCR) are shown for control mice (PBS) and pneumococcal-infected mice (D39). Numbers beside gated areas indicate the percentage of positive
cells in that area. Histograms show the percentages (n = 6) of various CD45+ lung cell populations positive for intracellular IFN-c or IL-17A (E).
doi:10.1371/journal.ppat.1001191.g002
Pneumolysin Promotes NLRP3 Inflammasome Activation
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Figure 3. Endotoxin-free PLY does not induce cytokine production by DC or macrophages but does enhance DC maturation in a
TLR4-independent manner. DC (A) or BMDM (B) from C57BL/6 mice were incubated with PLY (1 mg/ml or 0.5 mg/ml) or Pam3CSK (10 mg/ml) or
LPS (500 pg/ml) for 24 hours. Supernatants were analyzed for IL-12p40, TNF-a and IL-6. Results are presented as mean cytokine concentrations (+
SEM) for triplicate samples. (C) DC from C3H/HeN or C3H/HeJ mice were incubated with medium, PLY (1 mg/ml) or LPS (500 pg/ml). After 24 hours,
cells were washed and stained with antibodies specific for CD80, CD86, CD40 and MHC Class II. Immunofluorescence is shown for PLY- or LPS-treated
DC (black line) compared to untreated cells incubated with medium (grey histograms). Plots are representative of three independent experiments. (D)
Adoptive transfer of DC incubated with antigen and PLY promotes antigen-specific T cell responses. BALB/c mice were immunized subcutaneously in
the footpad with DC (56105 cells/mouse) that had been incubated overnight with medium only as a control or with KLH antigen (10 mg/ml) in the
presence or absence of PLY (1 mg/ml). 7 days later splenocytes were isolated and stimulated ex vivo with KLH (2 or 50 mg/ml). Proliferation was
measured by [3H]-thymidine incorporation after 4 days of culture and is expressed as mean cpm (+ SEM; n = 5). *** P,0.001 vs. adoptive transfer of
DC stimulated with KLH alone.
doi:10.1371/journal.ppat.1001191.g003
Pneumolysin Promotes NLRP3 Inflammasome Activation
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Figure 4. PLY synergizes with TLR agonists to enhance pro-inflammatory cytokine secretion by DC. (A) DC from C3H/HeN or C3H/HeJ
mice were incubated with PLY (1 mg/ml) for 1 hour before the addition of HkSp (10 bacteria:1 DC). After 24 hours supernatants were assayed for IL-
12p40, IL-6, IL-23 and TNF-a. Results are mean cytokine concentrations (+ SEM) for triplicate samples. *** P,0.001 vs. bacteria alone. (B) DC from C3H/
HeJ mice were incubated with PLY (1 mg/ml) for 1 hour before stimulation with TLR or NLR agonists; HkSp (10 bacteria:1 DC), CpG (4 mg/ml),
Pneumolysin Promotes NLRP3 Inflammasome Activation
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PLY, DC were incubated with HkSp or CpG in the presence or
absence of PLY or the W433F hemolysin mutant. PLY-driven IL-
1b secretion was hemolysin-dependent as the ability of W433F to
promote secretion of the cytokine was significantly less than wild-
type PLY (Fig. 4C).
IL-1b is synthesised inside cells as a biologically inactive
precursor that is processed by caspase-1 prior to its secretion.
Caspase-1 is itself produced as an inactive zymogen that must be
cleaved to generate the active p10 and p20 subunits. Since the
secretion of IL-1b requires both the transcription of IL-1b and
caspase-1 activation, we investigated how PLY promoted IL-1b
secretion in DC. We found that PLY alone promoted caspase-1
activation in DC and that this was independent of TLR4, as
processed (p10) caspase-1 was detected in DC lysates from both
C3H/HeN and C3H/HeJ mice (Fig. 4D). Pre-treatment of DC
with the caspase-1 inhibitor YVAD-fmk completely blocked the
synergy between PLY and PAM3Csk for IL-1b secretion (Fig. 4E),
confirming the importance of caspase-1 in PLY-induced IL-1b
secretion. In contrast, the enhancement of IL-1a secretion by the
toxin was not significantly affected, indicating that caspase-1 was
not required (Fig. 4E). The importance of caspase-1 in PLY-
induced IL-1b secretion was also confirmed using DC from
caspase-1 knockout mice, as the synergy between PLY and either
PAM3Csk or HkSp for IL-1b was dramatically reduced in
caspase-12/2 DC compared to wild-type DC (Fig. 5A).
The activation of caspase-1 is regulated by the assembly of
inflammasomes, cytoplasmic multiprotein complexes that contain
a nucleotide-binding oligomerization domain (NOD)-like receptor
(NLR) family member, such as NLRP3 or NLRC4 and caspase-1
[28]. We investigated the role of the NLRP3 inflammasome in
PLY-driven IL-1b secretion and found that the ability of PLY to
promote IL-1b secretion was compromised in cells from
NLRP32/2 mice compared to wild-type mice (Fig. 5B), but not
in DC from mice deficient in NLRP6 or NLRP12 (Fig. S6). In
particular, the synergy between PLY and HkSp for IL-1b secretion
was abrogated in DC from NLRP32/2 mice (Fig. 5B). This
marked defect in the ability of NLRP32/2 DC to secrete IL-1b in
response to stimulation with PLY was due to differences in IL-1b
processing, as Western blot analysis did not reveal altered proIL-
1b production in DC from NLRP32/2 mice compared to DC
from wild-type mice (Fig. S7). In contrast to IL-1b secretion, PLY
significantly enhanced bacteria-induced IL-1a secretion in DC
from both wild-type and NLRP32/2 mice (Fig. 5B). The adapter
protein ASC (apoptosis-associated speck like protein containing
CARD) is necessary for caspase-1 activation via NLRP3. PLY-
mediated enhancement of IL-1b secretion was also reduced in DC
from ASC2/2 mice, compared to wild-type mice (Fig. S8). DC
from caspase-12/2 (Fig. 5A) or NLRP32/2 (Fig. 5B) mice secreted
comparable concentrations of TNF-a to wild-type mice when
stimulated with PLY and TLR agonist, indicating that the ability
of these cells to produce inflammatory cytokines was not globally
compromised. Indeed, the ability of PLY to promote the secretion
of TNF-a, IL-6, IL-23, IL-12 and IL-10 was independent of
NLRP3 (Fig. 6). CpG was used as the TLR for these experiments
as it was the most effective TLR agonist to determine synergy with
PLY for this panel of cytokines, particularly IL-12p70. The IL-10
data indicate that PLY can promote secretion of both pro- and
anti-inflammatory cytokines, although the overall profile suggests
that PLY is a highly pro-inflammatory factor.
Having demonstrated that purified endotoxin-free PLY can
promote IL-1b secretion via the NLRP3 inflammasome, we next
investigated the role of NLRP3 in IL-1b production by DC in
response to live S. pneumoniae. Wild-type S. pneumoniae induced
robust IL-1b secretion by DC and this was dependent on PLY
since the PLY-deficient strain induced very little IL-1b secretion
(Fig. 7). In contrast, IL-1a, TNF-a and IL-6 secretion in response
to the PLY-deficient strain was comparable to, or greater than,
that induced by the wild-type bacteria. Thus, PLY appears to play
a vital and selective role in pneumococcus-induced IL-1b secretion
by DC. Furthermore, the induction of IL-1b secretion by the
pneumococcus was strongly dependent on NLRP3 (Fig. 7).
In order to further investigate the mechanisms by which PLY
may trigger caspase-1 activation and IL-1b secretion in DC, we
examined the involvement of some known factors implicated in
NLRP3 inflammasome activation such as reduced cytoplasmic
potassium concentration. It has been reported that the pore forming
toxins, Staphylococcus aureus a-toxin [29] and Aeromonas hydrophilia
aerolysin [30] induce the secretion of IL-1b and the activation of
caspase-1, respectively, by allowing the efflux of intracellular
potassium (K+). We therefore assessed whether K+ efflux could also
be the trigger for caspase-1 activation by PLY. The addition of
extracellular KCl to the medium (50 mM) significantly inhibited IL-
1b secretion by DC in response to PLY and PAM3Csk (Fig. 8A).
Interestingly, IL-1a secretion was also significantly reduced in the
presence of high potassium concentrations (Fig. 8A).
It has been proposed that the NLRP3 inflammasome may be
activated by lysosomal damage and the subsequent release of
cathepsin B into the cytoplasm of cells [31]. We investigated the
effect of inhibiting cathepsin B on PLY-induced IL-1 secretion and
found that inhibition with the specific cathepsin B inhibitor CA-
074-Me resulted in a significant reduction in IL-1b, but not IL-1a,
secretion by DC stimulated with PLY and PAM3CSk (Fig. 8B).
Furthermore, treating DC with bafilomycin A, which inhibits the
H+ ATPase system required for lysosomal acidification [32],
significantly reduced the enhancement of IL-1b and IL-1a, but not
TNF-a, by PLY (Fig. 8B).
The NLRP3 inflammasome is required for protection
against S. pneumoniae infection
To investigate the significance of PLY and pneumococcal-
induced inflammasome activation, NLRP32/2 and wild-type
control C57BL/6 mice were intranasally infected with S.
pneumoniae (strain D39). In contrast to control mice, which showed
a significant reduction in lung CFU 24 hr post-infection, bacterial
clearance was significantly compromised in NLRP32/2 mice and
Pam3CSK (10 mg/ml), zymosan (20 mg/ml) or MDP (20 mg/ml). Supernatants were assayed for IL-1a and IL-1b after 24 hours. Results are mean
cytokine concentrations (+ SEM) for triplicate samples. * P,0.05 and *** P,0.001 vs. agonist alone. (C) Haemolytic activity is required for the
promotion of IL-1b secretion by PLY. DC from C57BL/6 mice were incubated with medium alone (control), or with PLY or W433F for 1 hour before
stimulation with CpG (4 mg/ml) or HkSp (10 bacteria:1 DC). Following 24 hours incubation, supernatants were assayed for IL-1b. Results are mean
cytokine concentrations (+ SEM) for triplicate samples. ***, P,0.001 vs. agonist alone,### P,0.001 vs. PLY + agonist. (D) Activation of caspase-1 by
PLY. DC (16106/ml) from C3H/HeN (represented as TLR4 +) or C3H/HeJ (represented as TLR42) mice were stimulated with PLY (2 mg/ml) (73,143 HU/
mg) for 3, 6, 9, 12 or 24 hours or with medium (0 hours) as a control. Cell lysates were analysed for caspase-1 p10 expression by Western blot. (E) DC
from C3H/HeJ mice were incubated with or without the caspase-1 inhibitor YVAD-fmk (40 mM) for 30 minutes before the addition of PLY (1 mg/ml)
either alone or 1 hour before Pam3CSK (10 mg/ml). After 24 h supernatants were assayed for IL-1b, IL-1a and TNF-a by ELISA. *** P,0.001 vs. PAM3 +
PLY alone.
doi:10.1371/journal.ppat.1001191.g004
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no reduction in bacterial CFU was evident in the lungs of these
mice at this time-point (Fig. 9A).
To determine the role of PLY, mice were also infected with a
PLY-deficient isogenic mutant strain of D39 (PLN-A). Bacterial
CFU of PLN-A in lungs of control C57BL/6 mice at 24 hr post-
infection were significantly lower than in lungs of NLRP32/2mice
(Fig. 9B). In addition, although there were reductions in bacterial
CFU of PLN-A in lungs of both NLRP32/2 and control mice over
time, the reduction in control mice was significantly greater than
observed in NLRP32/2 mice (Fig. 9B). Therefore, NLRP3
appears to play a particularly important role in infection with
PLY-expressing S. pneumoniae, although the data with PLN-A
suggest that even in the absence of PLY, NLRP3 may play a role
in protective immunity.
These data indicate for the first time a role for NLRP3 in
protection against S. pneumoniae infection and this is the first
description of a role for NLRP3 in protection against a Gram-
positive bacterial pathogen.
Discussion
In mice, the cytokines IL-1b [27], IFN-c and IL-17A [19,20,21]
have been shown to play important protective roles in immunity
against pneumococci. Here we show that PLY strongly enhances
the secretion of IFN-c by splenocytes in vitro and is required for
IFN-c and IL-17A responses during pneumococcal infection in
vivo. NK cells are the principal cellular source of IFN-c in the lungs
following infection while cd T cells are the major producers of IL-
17A. This supports recent findings that cd T cells are a key source
of IL-17A production in vitro and in vivo in response to IL-1
stimulation [24] and pathogen-derived products [33]. The latter
study found that IL-17-producing cd T cells share a number of
Figure 6. In contrast to PLY-induced IL-1b secretion, the enhancement of TNF-a, IL-6, IL-10 and IL-12 by PLY is independent of
NLRP3. DC (6.256105/ml) from C57BL/6 or NLRP32/2 mice were incubated with medium alone or with various concentrations of PLY (0.2–0.75 mg/
ml) for 1 hour before the addition of CpG (4 mg/ml). After 24 hours supernatants were assayed for IL-1b, TNF-a, IL-6, IL-23, IL-10 and IL-12p70. Results
are mean cytokine concentrations (+ SEM) for triplicate samples. ** P,0.01 and *** P,0.001 vs. CpG alone.
doi:10.1371/journal.ppat.1001191.g006
Figure 5. The ability of PLY to enhance IL-1b secretion by DC is caspase-1 and NLRP3-dependent. (A) DC from wild-type C57BL/6 or
Caspase-12/2 were incubated with PLY (0.5 mg/ml) for 1 hour before the addition of Pam3CSK (10 mg/ml) or HkSp (10 bacteria:1 DC). IL-1b, IL-1a and
TNF-a concentrations were quantified in supernatants after 24 hours and are presented as mean values (+ SEM) from triplicate cultures. * P,0.05,
** P,0.01 and *** P,0.001 vs. agonist alone. (B) DC from wild-type C57BL/6 or NLRP32/2mice were incubated with PLY (0.5 mg/ml) for 1 hour before
the addition of Pam3CSK (10 mg/ml) or HkSp (10 bacteria:1 DC). After 24 h supernatants were assayed for IL-1b, IL-1a and TNF-a by ELISA. *** P,0.001
vs. agonist alone.
doi:10.1371/journal.ppat.1001191.g005
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characteristic features with Th17 cells. IL-1 and IL-23 play key
roles in the induction of IL-17A production by cd T cells and in
the differentiation and expansion of Th17 cells [24]. Other
cytokines, including IL-6 and TNF-a, have also been shown to be
important in Th17 cell differentiation [34,35,36]. Importantly, our
data show that PLY can synergize with TLR agonists to enhance
the secretion of IL-1a, IL-1b, IL-23, TNF-a and IL-6 by DC,
which can induce IL-17A production by cd T cells and promote
the differentiation and expansion of Th17 cells. The ability of
Freund’s complete adjuvant or LPS to induce antigen-specific
Th17 cell responses in vivo requires IL-1R1, indicating a key role
for IL-1 in adjuvant-driven Th17 cell responses [36].
Pneumolysin also strongly enhanced TLR agonist-induced IL-
12 secretion, which together with cytokines such as IFN-c and IL-
18, is important for Th1 differentiation and stabilization [37]. Like
IL-1b, active IL-18 also requires cleavage of its precursor form by
caspase-1 and enhanced levels have been reported in macrophages
co-stimulated with recombinant PLY and PLY-deficient S.
pneumoniae [38]. Since IFN-c produced by NK cells is important
for the instruction of Th1 responses [23], our demonstration of
NK cells producing IFN-c in the lungs of infected mice could
suggest subsequent promotion of pathogen-specific Th1 responses.
Likewise, it has been suggested that IL-17A derived from cd T
cells can promote Th17 responses [24] and we demonstrate that
there are IL-17A-producing cd T cells in the lungs of mice infected
with pneumococcus. Both of these effects were strongly dependent
on pneumolysin, suggesting that the toxin is a key factor in
pneumococcus-induced IFN-c secretion by NK cells and IL-17A
production by cd T cells. Furthermore, since IL-23R signalling
promotes the expansion and maintenance of cd T cells in response
to intracellular bacterial infection [39], the ability of pneumolysin
to promote both IL-1 and IL-23 production is likely to contribute
strongly to these cd T cell responses.
During pneumococcal infection, PLY may synergize with
pneumococcal or endogenous danger signals to induce the secretion
of inflammatory cytokines. Reduced concentrations of plasma IL-6
have been reported from mice infected with PLY-deficient S.
pneumoniae compared to isogenic wild-type pneumococci [40]. In
addition, IL-1 and TNF-a are induced during murine pneumococ-
cal disease [41] and elevated levels of both have been reported in
patients with pneumococcal meningitis. Notably, studies using mice
deficient in IL-1 receptor type 1 (IL-1R12/2) [42] or IL-1b [27]
have shown the importance of IL-1 in conferring resistance to
pneumococcal meningitis and pneumonia respectively. The latter
study found that IL-1b, but not IL-1a, plays a major role in
resistance to pneumococcal infection. Therefore, the inflamma-
somes, which are required for IL-1b processing and secretion, are
likely to be crucial components of the host defense to S. pneumoniae.
Shoma et al. recently reported that recombinant PLY stimulated the
secretion of IL-1a, IL-1b and IL-18 in a caspase-1 dependent
manner in macrophages and that this was augmented by co-
stimulation with pneumococci [38]. Importantly, we show here for
the first time that the enhancement of IL-1b secretion by PLY is
NLRP3-dependent. The ability of live pneumococci to promote IL-
1b secretion by DC is also strongly dependent on NLRP3. One of
the key observations in this study is that NLRP3 is required for
protective immunity against pneumococcal infection. The first
demonstration of a role for NLRP3 in defence against a Gram-
negative pathogen, Salmonella typhimurium, was recently described
[43], but our study is the first report to show that NLRP3 is required
for protection against a Gram-positive bacterium.
NLRP3 activation by PLY required lysosomal damage and the
release of cathepsin B, as inhibitors of these processes reduced PLY-
induced IL-1b secretion. Phagosomal rupture has previously been
shown to be important in NLRP3 inflammasome activation by
other compounds including silica crystals, aluminium salts and
Figure 7. Live S. pneumoniae promotes IL-1b secretion by DC in a NLRP3-dependent manner and this requires PLY. DC (6.256105/ml)
from C57BL/6 or NLRP32/2 mice were incubated for 24 hours with medium alone, with wild-type S. pneumoniae (D39; 10 bacteria:1DC) or with PLY-
deficient bacteria (PLN; 10 bacteria:1 DC). As a positive control for IL-1b secretion and NLRP3 inflammasome activation, DC were primed with LPS
(100 ng/ml) for 23 hours prior to one hour stimulation with ATP (2.7 mg/ml). Following incubation, supernatants were removed and assayed for IL-
1b, IL-1a, TNF-a and IL-6. Results are mean cytokine concentrations (+ SEM) for triplicate samples. *** P,0.001, NLRP32/2 vs. C57BL/6 DC stimulated
with the same treatments, ### P,0.001, D39 vs. PLN bacteria in C57BL/6 DC, NNN P,0.001, D39 vs. PLN bacteria in NLRP32/2 DC.
doi:10.1371/journal.ppat.1001191.g007
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microparticles [31,32,44] and a role for cathepsin B was recently
reported in the promotion of IL-1b secretion by the pore-forming
toxin tetanolysin O [45]. Furthermore, the ability of PLY to activate
NLRP3 was dependent on the haemolytic activity of the toxin.
Taken together, our data suggest that PLY-induced pore formation
results in K+ efflux from DC and intracellular changes including
lysosomal destabilization. The release of lysosomal products, such as
cathepsin B, into the cytosol may promote the generation of danger
signals, which are detected by NLRP3 or intermediary factors,
resulting in inflammasome assembly and caspase-1 activation.
Active caspase-1 could then process pro-IL-1b, which is generated
in response to a second stimulus such as a TLR/NLR ligand, into
mature IL-1b which is released from the cell.
Although a direct role for PLY in the induction of IL-1 or TNF-
a during pneumococcal disease has not been established, the
reduced inflammation and pathology in the lungs of mice infected
with PLY-deficient pneumococci compared to wild type strains [4]
suggests a diminished inflammatory cytokine response. In
particular, lower levels of T cell infiltration and neutrophil
recruitment into the lungs have been reported from mice infected
with PLY-deficient S. pneumoniae compared to wild-type pneumo-
cocci [4]. TNF-a and IL-1b are two of the key cytokines involved
in neutrophil recruitment in the lungs of mice infected
intratracheally with wild-type S. pneumoniae [46]. Additionally,
IL-17A plays a key role in neutrophil recruitment and its induction
in vivo is strongly dependent on IL-1 [34,36].
An additional major finding of this study is that the stimulatory
effects of PLY on DC and splenocyte cytokine secretion are
independent of TLR4. While we demonstrate that PLY can
promote expression of costimulatory molecules and proinflamma-
tory cytokines in DC, these effects are independent of TLR4. We
also show that PLY exerts adjuvant effects, promoting antibody
responses against a co-administered antigen in both wild-type and
TLR4-defective mice, indicating that the immunostimulatory
effects of PLY in vivo do not require TLR4. Therefore, further
studies into the involvement of pathogen recognition receptors in
sensing PLY in innate cells are warranted.
Streptococcus pneumoniae is a pathogen of significant clinical
importance and understanding its interaction with the immune
system is crucial. We propose that upon infection with S.
pneumoniae, PLY, in synergy with pneumococcal PAMPs promotes
the secretion of proinflammatory cytokines, particularly IL-1b,
that promote an inflammatory response and mediate protective
immunity. We identify PLY as a novel NLRP3 inflammasome
activator and show that the ability of the live bacterium to
promote IL-1b secretion is also strongly NLRP3-dependent. More
importantly, NLRP3 is required for protective immunity against
respiratory pneumococcal infection.
Figure 8. PLY-induced IL-1b secretion by DC is dependent on potassium efflux and phagosomal rupture. (A) DC from C3H/HeJ mice
were incubated with medium alone or supplemented with KCl (50 mM) for 30 minutes before addition of PLY (1 mg/ml) either alone or 1 hour before
Pam3CSK (10 mg/ml). After 24 hours, supernatants were assayed for IL-1b, IL-1a and TNF-a. ** P,0.01 and *** P,0.001 vs. PAM3 + PLY. (B) DC from
C3H/HeJ mice were incubated with a cathepsin B inhibitor CA-074-Me (10 mM) or bafilomycin A (250 nM) for 30 minutes before addition of PLY (1 mg/
ml) either alone or 1 hour before PAM3Csk (10 mg/ml). After 24 hours, supernatants were assayed for IL-1b, IL-1a and TNF-a. *** P,0.001 vs. PAM3 +
PLY. All cytokine concentrations are presented as the mean (+ SEM) for triplicate samples.
doi:10.1371/journal.ppat.1001191.g008
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Materials and Methods
Ethics statement
Experiments on mice carried out at Trinity College Dublin were
conducted under Irish Department of Health guidelines with
ethical approval from the TCD ethics committee. Mice experi-
ments carried out at the University of Leicester were done under
UK Home Office guidelines with ethical approval from the UK
Home Office.
Reagents
CpG ODN 1826 was from Oligos Etc. E. coli LPS, Serotype
R515 was obtained from Alexis Biochemicals while all other TLR
agonists were obtained from InvivoGen.
Recombinant PLY was expressed in E. coli and purified as
previously described [47]. Unless otherwise stated the specific
haemolytic activity of PLY was 100,000 HU/mg. The toxin was
passed three times through an EndoTrap endotoxin removal
column (Profos AG, Germany) after which LPS was undetectable
using the PyroGene Recombinant Factor C assay (Lonza; detection
limit 0.01 EU/ml). S. pneumoniae serotype 2, strain D39 (NCTC
7466), was obtained from the National Collection of Type Culture,
London, UK. The pneumolysin-negative mutant, PLN-A, was
made by insertion duplication mutagenesis as described previously
[2]. Heat-killed S. pneumoniae (HkSp) D39 was obtained by boiling
16108 CFU in phosphate buffered saline (PBS) for 20 minutes and
checking for viability by colony counts and plate streaking. PLY
W433F was a gift from The Netherlands Vaccine Institute.
Mice for culture of macrophages, DC or splenocytes
Female BALB/c, C57BL/6, C3H/HeN and C3H/HeJ mice
were obtained from Harlan Olac (UK) and were used at 9–16
weeks old. NLRP32/2 mice were bred in the Bioresources Unit in
Trinity College Dublin. Animals were maintained according to the
regulations of the EU and the UK or the Irish Department of
Health as appropriate. Caspase12/2 DC were kindly provided by
Dr. Katherine Fitzgerald (UMass, USA).
Culture of DC and BMDM
DC and BMDM were prepared by culturing murine bone
marrow cells using protocols adapted from Lutz et al. [48] and Davies
et al. [49]. Briefly, bone marrow cells were flushed aseptically from
the femurs and tibia of mice. For culture of DC, cells were grown in
RPMI 1640 medium (Biosera) containing 8% v/v fetal calf serum
(FCS; Biosera), 100 U/ml penicillin, 100 mg/ml streptomycin, and
100 mM L-glutamine (Gibco) and supplemented with supernatant
from a granulocyte-macrophage colony-stimulating factor (GM-
CSF)-expressing cell line (final concentration of 20 ng/ml GM-
CSF). Macrophages were grown in Dulbecco’s Modified Eagle’s
Medium containing 20 ng/ml M-CSF. Cultures were maintained in
a humidified atmosphere (5% CO2) at 37uC, and medium was
replaced on days 3, 6 and 8 for DC or days 2 and 4 for BMDM. On
day 6 (BMDM) or day 10 (DC) of culture, cells were plated and
stimulated with PLY and/or TLR agonists 24 hours later.
Effect of PLY on DC maturation and cytokine production
DC (6.256105/ml) were cultured at 37uC for 24 h with
medium, PLY or W433F alone, TLR and NLR agonists
(PAM3Csk4, LPS, zymosan, MDP, CpG) alone, HkSp alone or
PLY or W433F and TLR agonists or HkSp together. In certain
experiments, DC were incubated with YVAD-fmk (Bachem), KCl
(Sigma), CA-074-ME (Sigma) or Bafilomycin A (Sigma) 30 mins
before the addition of PLY and/or TLR agonists. At the end of the
incubation, supernatants were removed and cytokine concentra-
tions were determined by ELISA using pairs of antibodies
purchased from BD Biosciences (IL-6 and IL-12p40) or R&D
Systems (IL-1a, IL-1b, TNF-a, IL-12p70, IL-10 or IL-23)
according to the manufacturer’s specifications. Alternatively, cells
were recovered and used for immunofluorescence analysis or
Western Blotting. The expression of DC surface markers was
assessed using fluorochrome-labelled antibodies against murine
CD80, CD86, I-A/I-E, CD11c and CD40 (BD Biosciences). After
blocking for 10 minutes on ice with anti-mouse CD16/CD32 (BD
Biosciences) followed by incubation with antibodies for 30 minutes
on ice, cells were washed and immunofluorescence analysis was
performed on a CyAN (Dako) flow cytometer using FlowJo
software (Tree Star). For Western blot analysis, cells were lysed in
Laemmli sample buffer, samples were boiled and proteins
separated by SDS/PAGE. Caspase-1 p10 was detected as
previously described [44].
Figure 9. The NLRP3 inflammasome is required for protection
against S. pneumoniae infection. C57BL/6 and NLRP32/2 mice were
nasally infected with 16106 CFU of wild-type S. pneumoniae (strain D39)
or PLY-deficient S. pneumoniae (PLN-A). Mice were sacrificed at 0 and
24 hours post-infection and bacterial CFU in lung homogenates were
assessed. Data are expressed as mean (+ SEM) CFU per mg of lung
tissue (log10) for five mice per group. * P,0.05 and ** P,0.01 vs.
0 hours p.i. in the same mouse strain, # P,0.05 and ## P,0.01
C57BL/6 24 hours p.i. vs. NLRP32/2 24 hours p.i. (A) Infection with wild-
type bacteria. (B) Infection with PLY-deficient bacteria.
doi:10.1371/journal.ppat.1001191.g009
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Effect of S. pneumoniae on DC cytokine production
DC (6.256105/ml) from C57BL/6 and NLRP32/2 mice were
cultured at 37uC in RPMI 1640 medium (Biosera) containing 8%
v/v FCS (Biosera) and 100 mM L-glutamine (Gibco) in the
absence of antibiotics. Cells were stimulated with PBS or with
wild-type (D39; 10 bacteria:1 DC) or PLY-deficient S. pneumoniae
(PLN; 10 bacteria:1 DC) in PBS. Following 24 h incubation,
supernatants were removed and analysed for cytokine production
by ELISA.
Adoptive transfer of PLY and antigen-stimulated DC
DC (16106/ml) were incubated overnight with medium alone
or with KLH (10 mg/ml) with or without PLY (1 mg/ml). After
extensive washing, cells (16105/mouse) were injected subcutane-
ously into the footpads of mice. After 7 days, splenocytes were
isolated and resuspended at 26106 cells/ml in RPMI medium,
supplemented with 8% v/v FCS. Cells were cultured in triplicate
with KLH (2 or 50 mg/ml) or with medium only as a negative
control. Proliferative responses were assessed after 4 days of
culture by [3H]-thymidine incorporation.
Effect of PLY on cytokine production by spleen cells
Splenocytes were isolated from C3H/HeN or C3H/HeJ mice
by passing spleens through a 70 mm cell strainer (BD Falcon). After
lysing erythrocytes in 0.88% w/v NH4Cl solution for 5 minutes
and washing, cells were incubated in 96-well plates (16106/ml) in
RPMI medium with 8% v/v FCS plus antibiotics. Splenocytes
were stimulated for 72 hours with PLY in the presence of plate-
bound anti-CD3 (BD Biosciences) or HkSp and in some cases for a
further 24 hours with PMA (Sigma Aldrich) and ionomycin
(Sigma Aldrich). Supernatants were removed after 72 or 96 hours
and tested by ELISA for IL-10, IL-17A (R&D Systems), IFN-c and
IL-5 (BD Biosciences).
Intranasal infection of mice with wild-type and
PLY-deficient pneumococci
The pneumococcal infection studies were done at the University
of Leicester under UK Home Office guidelines or in Trinity
College Dublin under Irish Department of Health guidelines.
Wild-type S. pneumoniae serotype 2 strain D39, NCTC 7466
(NCTC, London, UK) was used. An isogenic PLY-negative
mutant, PLN-A, has been described previously [2]. Pneumococci
were cultured on blood agar base with 5% v/v horse blood, or in
brain heart infusion broth (BHI; Oxoid, Basingstoke, UK) with
20% v/v foetal bovine serum (Gibco, Paisley, UK), supplemented
with 1 mg/ml erythromycin (Sigma, Poole, UK) for PLN-A. Before
use, pneumococci were passaged through mice, as described
previously [4] and aliquots stored at 280uC. When required, the
suspension was thawed at room temperature, and bacteria were
harvested by centrifugation before resuspension in sterile PBS.
Female outbred MF1, BALB/c, C57BL/6 (Harlan, Bichester,
UK) or NLRP32/2 (bred in the Bioresources Unit of Trinity
College Dublin) mice (9–10 weeks old, 30–35 g) were used for
infection studies. Mice were lightly anaesthetized, as described
previously [4], and 50 ml PBS containing 16106 CFU S. pneumoniae
was administered into the nostrils. The inoculum dose was
confirmed by viable count following infection. At pre-chosen time
intervals following infection, mice were sacrificed and lungs
removed, weighed, and homogenised with an Ultra-Turrax T8
homogeniser (IKA, Germany). CFU bacterial counts were
determined by viable count on blood agar plates as described
previously [4]. IFN-c and IL-17A concentrations in lung
homogenates were measured by ELISA (BD Biosciences).
Analysis of intracellular IL-17A and IFN-c production in
the lungs of infected mice
Forty-eight hours post-infection of BALB/c mice with D39 wild-
type S. pneumoniae (as described in the previous section), mice were
sacrificed, lungs removed and cells isolated as described previously
[4]. For intracellular cytokine staining, lung cells were cultured for
five hours at 56105 cells/well in round-bottomed 96-well plates in
RPMI 10% FCS supplemented with GolgiPlug (BD Biosciences),
according to manufacturer’s instructions, to block cellular secretion
of cytokines. Media was further supplemented with 500 ng/ml
ionomycin and 50 ng/ml PMA. Following culture, cells were
washed and stained with antibodies against extracellular markers
(anti-CD3, anti-CD4, anti-CD8, anti-NKp46, anti-NK1.1, anti-
CD45 or anti-cdTCR; BioLegend or eBioscience). Cells were then
incubated with Fix/Perm solution (BD Biosciences) for 20 minutes
before washing in Perm/Wash buffer (BD Biosciences). Staining
with antibodies against intracellular cytokines was performed with
anti-IL17A and anti-IFN-c antibodies diluted in Perm/Wash
buffer. After staining, cells were washed and resuspended in PBS
3% (v/v) FCS prior to data collection.
Statistical analyses
Unless otherwise stated, data were compared by one-way
ANOVA. The Tukey-Kramer multiple-comparison test was used
to identify significant differences between individual groups.
Methods for supporting data
Methods for supporting data are described in Methods S1.
Supporting Information
Methods S1 Supplementary Materials and Methods
Found at: doi:10.1371/journal.ppat.1001191.s001 (0.02 MB RTF)
Figure S1 Sensitivity of splenocytes to toxic concentrations of
PLY is independent of TLR4. Splenocytes (16106 cells/ml) from
either C3H/HeN or C3H/HeJ mice were incubated with medium
alone or with various concentrations of PLY (1.6 ng/ml-5 mg/ml)
for 6, 24 or 72 hours. After stimulation, cells were washed, stained
with Annexin V-FITC and propidium iodide (PI; 1 mg/ml) and
analysed by flow cytometry for dye uptake. Cell death is expressed
as the percentage of cells that took up PI out of the total cell
number and is representative of data from two independent
experiments. (A) Representative dot plots showing AnnexinV and/
or PI positive splenocytes from C3H/HeJ mice following
stimulation with PLY for 6 hours. (B) Cell death in splenocytes
from both C3H/HeN and C3H/HeJ mice stimulated with PLY
for 24 hours. (C) Cell death in splenocytes from both C3H/HeN
and C3H/HeJ mice stimulated with PLY for 72 hours.
Found at: doi:10.1371/journal.ppat.1001191.s002 (0.80 MB TIF)
Figure S2 Growth of wild-type and pneumolysin-deficient S.
pneumoniae in the lungs of infected mice. (A) Acute pneumonia model.
MF1 mice were infected as described in Fig. 2A. Bacterial CFU were
determined in the lungs of infected mice at 0, 24 and 48 hours post-
infection. ** P,0.01 vs. WT. (B) Resolving pneumonia model.
BALB/c mice were infected intranasally as described in Fig. 2B.
Bacterial CFU were determined in the lungs of infected mice at 0, 24
and 48 hours post-infection. *, P,0.05, ** P,0.01 vs. WT.
Found at: doi:10.1371/journal.ppat.1001191.s003 (0.14 MB TIF)
Figure S3 Sensitivity of DC to toxic concentrations of PLY is
independent of TLR4. DC (6.256105 cells/ml) from either C3H/
HeN or C3H/HeJ mice were incubated with medium alone or
with various concentrations of PLY (0.1–6 mg/ml) for 6 or
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24 hours. After stimulation, cells were washed, stained with
Annexin V-FITC and propidium iodide (PI; 1 mg/ml) and
analysed by flow cytometry for dye uptake. Cell death is expressed
as the percentage of cells that took up PI out of the total cell
number and is representative of data from three independent
experiments. (A) Cell death in DC from C3H/HeJ mice. (B) Cell
death in DC from both C3H/HeN and C3H/HeJ mice stimulated
with 6 mg/ml PLY. (C) Representative dot plots showing
AnnexinV and/or PI positive DC from C3H/HeJ mice following
stimulation with PLY for 6 hours.
Found at: doi:10.1371/journal.ppat.1001191.s004 (0.51 MB TIF)
Figure S4 PLY enhances antibody titres to co-administered
KLH independently of TLR4. (A) and (B) Female BALB/c mice
were immunized s.c. in the footpad with PBS, KLH (10 mg), or
KLH (10 mg) and PLY (10 mg). (A) Splenocytes and popliteal
lymph node cells, isolated 7 days later, were stimulated with KLH
(10 or 50 mg/ml), medium alone or PMA and anti-CD3.
Supernatants were removed after 3 days and were tested for IL-
5, IFN-c, and IL-17 by immunoassay. Results represent the mean
(+ SEM) of three mice per group and are representative of at least
three independent experiments. (B) Anti-KLH IgG, IgG1, IgG2a
and IgG2b titres were determined in serum, recovered 7 days post-
immunization, by ELISA. * P,0.05, ** P,0.01 and *** P,0.001,
Student’s t test. (C) C3H/HeN and C3H/HeJ mice were
immunized s.c. in the footpad with PBS, KLH (10 mg), or KLH
(10 mg) and PLY (1 mg). Anti-KLH IgG1 and IgG2a titres were
determined in serum, recovered 7 days post-immunization, by
ELISA. * P,0.05 and ** P,0.01, Student’s t test.
Found at: doi:10.1371/journal.ppat.1001191.s005 (0.29 MB TIF)
Figure S5 PLY synergizes with heat-killed pneumococci to
enhance IL-6 and TNF-a production by BMDM. BMDM
(6.256105/ml) from C57BL/6 mice were incubated with PLY
(1 mg/ml) for 1 hour before the addition of HkSp (10 bacteria:1
cell). IL-6 and TNF-a concentrations were measured by ELISA in
supernatants removed after 24 hours. Values are represented as
mean cytokine concentrations (+ SEM) from triplicate samples.
** P,0.01 and *** P,0.001 vs. bacteria alone.
Found at: doi:10.1371/journal.ppat.1001191.s006 (0.11 MB TIF)
Figure S6 PLY promotes IL-1b secretion in DC in a NLRP6-
and NLRP12-independent manner. DC from wild-type C57BL/6,
NLRP62/2 or NLRP122/2 mice were incubated with PLY
(0.5 mg/ml) for 1 hour before the addition of LPS (500 pg/ml). IL-
1b concentrations were quantified in supernatants after 24 hours
and are presented as mean values (+ SEM) from triplicate cultures.
*** P,0.001 vs. LPS alone.
Found at: doi:10.1371/journal.ppat.1001191.s007 (0.19 MB TIF)
Figure S7 The production of pro-IL-1b in response to TLR
activation is not compromised in NLRP32/2 DC. DC from wild-
type C57BL/6 (represented as c57) or NLRP32/2 (represented as
ko) mice were stimulated with PLY (0.5 mg/ml) for 1 hour before
the addition of PAM3Csk (10 mg/ml) and incubated for 24 hours.
Pro-IL-1b in cell lysates was detected by Western blot.
Found at: doi:10.1371/journal.ppat.1001191.s008 (0.49 MB TIF)
Figure S8 The ability of PLY to enhance IL-1b secretion is
compromised in ASC2/2 DC compared to wild-type DC. DC
from wild-type C57BL/6 or ASC2/2 mice were incubated with
PLY (1 mg/ml) for 1 hour before the addition of Pam3CSK
(10 mg/ml). After 24 hours supernatants were assayed for IL-1b,
IL-1a and TNF-a. * P,0.05 and *** P,0.001 vs. PAM3 alone.
Found at: doi:10.1371/journal.ppat.1001191.s009 (0.23 MB TIF)
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